NKTX - Latest News
Nkarta, Inc. (NKTX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $150.2M. Beta to the broader market is 0.94.
The article list below shows the most recent NKTX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent NKTX Headlines
Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance
defenseworld.net - Sep 28, 2026
Nkarta (NASDAQ: NKTX) said it expects to present initial clinical data from its autoimmune disease programs at the American College of Rheumatology's
Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance
marketbeat.com - Sep 27, 2026
Nkarta NASDAQ: NKTX said it expects to present initial clinical data from its autoimmune disease programs at the American College of Rheumatology's 20
Nkarta (NASDAQ:NKTX) Stock Falls 3.5% – Here’s Why
defenseworld.net - Sep 27, 2026
Nkarta, Inc. (NASDAQ: NKTX - Get Free Report)'s stock price fell 3.
Nkarta to Participate in September Investor Conferences
globenewswire.com - Sep 10, 2026
SOUTH SAN FRANCISCO, Calif. , Sept.
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
globenewswire.com - Sep 8, 2026
SOUTH SAN FRANCISCO, Calif. , Sept.
How News Affects NKTX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track NKTX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked NKTX news questions
- What is the latest NKTX news headline?
- The most recent NKTX headline (Sep 28, 2026) is "Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the NKTX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What NKTX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual NKTX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.